Long COVID After Acquisition of the Omicron Variant of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) During Pregnancy Compared With Outside of Pregnancy.

Saved in:
Bibliographic Details
Title: Long COVID After Acquisition of the Omicron Variant of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) During Pregnancy Compared With Outside of Pregnancy.
Authors: Metz TD; University of Utah Health, Salt Lake City, Utah; Massachusetts General Hospital, Boston, Massachusetts; George Washington University, Washington, DC; University of California, San Francisco, San Francisco, and Stanford University, Palo Alto, California; Duke University, Durham, University of North Carolina at Chapel Hill, Chapel Hill, and WakeMed Health and Hospitals, Raleigh, North Carolina; University of New Mexico, Albuquerque, New Mexico; RECOVER Patient, Caregiver, or Community Advocate Representative, NYU Grossman School of Medicine, Mount Sinai Medical Center, and Columbia University, New York, and New York Presbyterian Queens, Queens, New York; University of Illinois Chicago and Northwestern University, Chicago, and NorthShore University Health System, Evanston, Illinois; The Ohio State University, Columbus, The MetroHealth System, Case Western Reserve University, and Case Western Reserve University and University Hospitals of Cleveland, Cleveland, TriHealth Good Samaritan Hospital, Cincinnati, and Wright State University Boonshoft School of Medicine, Dayton, Ohio; University of Alabama at Birmingham, Birmingham, Alabama; University of Arizona, Phoenix, Arizona; West Virginia University, Morgantown, West Virginia; University of Colorado School of Medicine, Aurora, Colorado; Christiana Care Health System, Newark, Delaware; University of Texas at Houston, Houston, University of Texas Medical Branch at Galveston, Galveston, and University of Texas Health Sciences Center San Antonio, San Antonio, Texas; Emory University, Atlanta, Georgia; Medical College of Wisconsin, Milwaukee, Wisconsin; Saint Peter's University Hospital, New Brunswick, New Jersey; University of Pennsylvania, Philadelphia, and University of Pittsburgh, Pittsburgh, Pennsylvania; Yale School of Medicine, New Haven, Connecticut; and Brown University, Providence, Rhode Island., Reeder HT, Clifton RG, Flaherman V, Aragon LV, Baucom LC, Beamon CJ, Braverman A, Brown J, Carmilani M, Cao T, Chang A, Costantine MM, Dionne JA, Gibson KS, Gross RS, Guerreros E, Habli M, Hess R, Hillier L, Hodder S, Hoffman MC, Hoffman MK, Huang W, Hughes BL, Jia X, Kale M, Katz SD, Laleau V, Mendez-Figueroa H, McComsey GA, Ofotokun I, Okumura MJ, Pacheco LD, Palatnik A, Palomares KTS, Parry S, Pettker CM, Plunkett BA, Poppas A, Ramsey P, Reddy UM, Rouse DJ, Saade GR, Sandoval GJ, Sciurba F, Simhan HN, Skupski DW, Sowles A, Thorp JM Jr, Tita ATN, Wiegand S, Weiner SJ, Yee LM, Horwitz LI, Foulkes AS, Jacoby VL
Corporate Authors: NIH RECOVER (Researching COVID to Enhance Recovery) Consortium
Source: Obstetrics and gynecology [Obstet Gynecol] 2026 Mar 01; Vol. 147 (3), pp. 404-414. Date of Electronic Publication: 2025 Oct 02.
Publication Type: Journal Article; Observational Study; Multicenter Study; Comparative Study
Journal Info: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0401101 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-233X (Electronic) Linking ISSN: 00297844 NLM ISO Abbreviation: Obstet Gynecol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1873-233X
DOI:10.1097/AOG.0000000000006067